Dorzolamide HCl Ophthalmic Solution IP is a trusted and effective treatment for reducing elevated intraocular pressure (IOP) in patients with open-angle glaucoma and ocular hypertension. Formulated with Dorzolamide Hydrochloride 2% w/v, this carbonic anhydrase inhibitor decreases the production of aqueous humor in the eye, thereby significantly lowering IOP and helping prevent optic nerve damage and potential vision loss. This solution can be used as monotherapy or as an adjunct to other IOP-lowering medications when additional pressure control is required.
Dorzolamide Hydrochloride 2% w/v: A carbonic anhydrase inhibitor that reduces aqueous humor secretion, effectively lowering intraocular pressure.
Effective Reduction of High IOP: Helps manage elevated eye pressure in glaucoma and ocular hypertension patients.
Protects Optic Nerve Health: Reduces pressure-related damage and slows disease progression.
Suitable for Monotherapy & Combination Use: Can be used alone or alongside other glaucoma medications for enhanced control.
Trusted Ophthalmic Solution: Formulated under sterile, high-quality standards for safety and consistency.
Instill the prescribed number of drops into the affected eye(s), usually 2–3 times daily or as directed by an ophthalmologist. Do not touch the dropper tip to prevent contamination.
May include burning sensation, stinging, blurred vision, eye discomfort, or bitter taste. Seek medical attention if symptoms persist or become severe.
Globus Labs brings you WHO-GMP–certified, high-quality Dorzolamide HCl sourced from reputed pharmaceutical manufacturers. Dorzobus is formulated to deliver safe, potent, and clinically trusted support.
Whether you’re seeking a franchise opportunity, exploring wholesale distribution, or evaluating Globus Labs for international trade, we’re here to help you build a strong, profitable partnership. Let’s discuss how we can grow together and create meaningful value for your business.